Related Experiment Video
Updated: May 24, 2026
10:36
Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
Published on: March 17, 2016
Estrogen receptor β transcript variants associate with oncogene expression in endometrial cancer
Julia Häring1, Maciej Skrzypczak, Anette Stegerer
1Department of Obstetrics and Gynecology, University Medical Center Regensburg, Regensburg, Germany.
International Journal of Molecular Medicine
|March 2, 2012
Summary
Estrogen receptor beta (ERβ) variants are elevated in endometrial cancer and correlate with oncogenes. Knockdown of ERβ reduced cancer cell oncogene expression, suggesting ERβ plays a role in endometrial cancer development.
Area of Science:
- Endocrinology
- Molecular Biology
- Oncology
Background:
- The human ESR2 gene encodes estrogen receptor beta (ERβ) and splice variants with distinct cellular functions.
- The specific role of ERβ in endometrial cancer pathogenesis remains largely undefined.
- Estrogen signaling pathways are implicated in various gynecological cancers.
Purpose of the Study:
- To investigate the expression of ERβ1, ERβ2, and other ERβ transcript variants in endometrial cancer.
- To determine the association between ERβ variants and key cancer-related genes, including oncogenes.
- To elucidate the functional impact of ERβ on oncogene expression in endometrial adenocarcinoma cells.
Main Methods:
- Quantitative real-time PCR (RT-qPCR) was used to analyze ERβ transcript variant expression in 74 human endometrium and endometrial cancer samples.
- Correlation analysis was performed between ERβ variant expression and selected cancer-related genes (MYBL2, HER2).
- siRNA-mediated knockdown of ERβ was conducted in HEC-1A endometrial adenocarcinoma cells to assess functional effects.
Main Results:
- Expression of four ERβ transcript variants was significantly increased in endometrial cancer tissue, particularly in G3 tumors, compared to postmenopausal endometrium.
- Expression of ERβ1, ERβ2, ERβ5, and five other variants correlated with the oncogenes MYBL2 or HER2 in endometrial cancer specimens.
- siRNA-triggered knockdown of ERβ resulted in a significant decrease in MYBL2 mRNA and protein levels within endometrial cancer cells.
Conclusions:
- Elevated ERβ transcript levels in endometrial cancer tissues, especially their correlation with oncogene expression, indicate a potential role for ERβ in endometrial carcinogenesis.
- The functional studies demonstrate that ERβ influences the expression of MYBL2, a key oncogene, in endometrial cancer cells.
- These findings suggest that ERβ may be a significant factor in the development and progression of endometrial cancer, warranting further investigation.
Related Concept Videos
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
01:32RNA Splicing
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
01:15Receptor Downregulation in MVBs
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
02:39lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
03:18Non-LTR Retrotransposons
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...